Interstitial Brachytherapy of Malignant Gliomas: The Memorial Sloan-Kettering Cancer Center Experience

  • M. G. Malkin
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 135)


Malignant gliomas remain incurable primary brain tumors despite the dedicated efforts over many decades of hundreds of clinical scientists worldwide. Any new procedure that offers a rationale for better tumor control is seized upon and applied in the hope that theory can be translated into practice, and that treatment can be translated into longer survival. One of these new techniques is interstitial brachytherapy, the stereotactic implantation of radioactive seeds directly into the tumor. In Europe this technique has been most widely applied to the treatment of low-grade gliomas, as discussed by Dr. Ostertag at this symposium. In North America the emphasis during the past 10 years has been on the application of this method to the treatment of malignant gliomas. In 1990 at least 50 institutions in North America were licensed by the manufacturer of 125I seeds to treat patients with brain tumors. This chapter reviews the experience with interstitial brachytherapy at Memorial Sloan-Kettering Cancer Center since 1986.


Malignant Glioma Radiation Necrosis Karnofsky Performance Score Compute Tomo Interstitial Brachytherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bernstein M, Laperriere N, Leung P, McKenzie S (1990) Interstitial brachytherapy for malignant brain tumors: preliminary results. Neurosurgery 26: 371–380PubMedCrossRefGoogle Scholar
  2. Gutin PH et al (1987) Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. J Neurosurg 67: 864–873PubMedCrossRefGoogle Scholar
  3. Hochberg FH, Pruitt A (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907–911PubMedGoogle Scholar
  4. Kumar PP, Good RR, Jones EO, Skultety FM, Leibrock LG, McComb RD (1988) Contrast-enhancing computed tomography ring in glioblastoma multiforme after intraoperative endocurietherapy. Cancer 61: 1759–1765PubMedCrossRefGoogle Scholar
  5. Larson DA, Gutin PH, Leibel SA, Phillips TL, Sneed PK, Wara WM (1990) Stereotaxic irradiation of brain tumors. Cancer 65: 792 799Google Scholar
  6. Sapozink MD, Moeller JM, McDonald PM, Heilbrun MP (1987) Improved precision of interstitial brain tumor irradiation using the BRW CT stereotaxic guidance system. Int J Radiat Oncol Biol Phys 13: 1753–1760PubMedCrossRefGoogle Scholar
  7. Saw CB, Suntharalingham N, Ayyangar KM, Tupchong L (1989) Dosimetric considerations of stereotactic brain implants. hit J Radiat Oncol Biol Phys 17: 887–891Google Scholar
  8. Szikla G, Schlienger M, Blond S, Daumas-Duport C, Missir O, Miyahara S, Musolino A, Schaub C (1984) Interstitial and combined interstitial and external irradiation of supratentorial gliomas Results in 61 cases treated 1973–1981. Acta Neurochir Suppl 33: 355–362Google Scholar
  9. Ten Haken RK, Diaz RF, McShan DL, Fraass BA, Taren JA, Hood TW (1988) From manual to 3-D computerized treatment planning for 125I stereotactic brain implants. hit J Radiat Oncol Biol Phys 15: 467–480Google Scholar
  10. Walker MD et al (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49: 333–343PubMedCrossRefGoogle Scholar
  11. Walker MD, Strike TA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5: 1725–1731PubMedGoogle Scholar
  12. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG (1989) Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16: 1405–1409PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • M. G. Malkin
    • 1
  1. 1.Department of NeurologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations